Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$16.18
+0.37%
Mkt Cap $2.07B
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$12.60
Range $6.00 – $16.00
Implied Upside
-22.1%
Consensus $12.60 vs current $16.18
NASDAQ·Healthcare·Biotechnology
$16.18
+0.37%
Mkt Cap $2.07B
No recent rating data.
Price Target (9 analysts)
$12.60
Range $6.00 – $16.00
-22.1%
Consensus $12.60 vs current $16.18